LAMISIL 250 (Lamisil 250 mg)

Generic Name: terbinafine

This pill with imprint "LAMISIL 250" is White, Round and has been identified as Lamisil 250 mg. It is manufactured by Novartis Pharmaceuticals.

Lamisil is used in the treatment of onychomycosis, toenail; tinea capitis; tinea corporis; cutaneous candidiasis; tinea pedis (and more), and belongs to the drug class miscellaneous antifungals. There is no proven risk in humans during pregnancy. Lamisil 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Lamisil

Generic Name:

terbinafine

Imprint:

LAMISIL 250

Strength:

250 mg

Color:

White

Size:

11.00 mm

Shape:

Round

Availability:

Prescription only

Drug Class:

Miscellaneous antifungals

Pregnancy Category:

B - No proven risk in humans

CSA Schedule:

Not a controlled drug

Manufacturer:

Novartis Pharmaceuticals

National Drug Code (NDC):

00078-0179

Inactive Ingredients:

silicon dioxide
hypromelloses
magnesium stearate
microcrystalline cellulose
sodium starch glycolate type A potato

Note: Inactive ingredients may vary.

Imprint Code FAQ's

Other Manufacturers / Repackagers:

NDC Code	Manufacturer / Repackager
55289-0513	PDRX Pharmaceuticals Inc (repackager)
54868-4008	Physicians Total Care Inc (repackager)
49999-0466	Lake Erie Medical and Surgical Supply (repackager)

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.